Coronavirus Disease 2019 and Cardiovascular Implications
Overview
Affiliations
: The coronavirus disease 2019 (COVID-19) has important implications for the cardiovascular care of patients. COVID-19 interacts with the cardiovascular system on multiple levels, increasing morbidity in patients with underlying cardiovascular conditions and favoring acute myocardial injury and dysfunction. COVID-19 infection may also have long-term implications for overall cardiovascular health. Many issues regarding the involvement of the cardiovascular system remain controversial. Despite angiotensin-converting enzyme 2 serving as the site of entry of the virus into the cells, the role of angiotensin-converting enzyme inhibitors or AT1 blockers requires further investigation. Therapies under investigation for COVID-19 may have cardiovascular side effects. Treatment of COVID-19, especially the use of antivirals, must be closely monitored. This article is a review of the most updated literature.
Askar M, Karaduman M, Coldur R, Askar S Ann Thorac Med. 2024; 19(1):96-104.
PMID: 38444992 PMC: 10911235. DOI: 10.4103/atm.atm_172_23.
Sljivo A, Brigic L, Abdulkhaliq A, Dadic I, Reiter L, Sirucic I Mater Sociomed. 2024; 35(4):290-294.
PMID: 38380286 PMC: 10875953. DOI: 10.5455/msm.2023.35.290-294.
Groen R, de Graaf M, Stoger J, van Dijkman P, Jukema J, Schalij M Am Heart J Plus. 2023; 27:100280.
PMID: 36852285 PMC: 9946728. DOI: 10.1016/j.ahjo.2023.100280.
Zuin M, Rigatelli G, Bilato C, Quadretti L, Roncon L, Zuliani G J Cardiovasc Med (Hagerstown). 2022; 23(12):773-778.
PMID: 36166326 PMC: 9671546. DOI: 10.2459/JCM.0000000000001354.
A year in heart failure: an update of recent findings.
Stretti L, Zippo D, Coats A, Anker M, von Haehling S, Metra M ESC Heart Fail. 2021; 8(6):4370-4393.
PMID: 34918477 PMC: 9073717. DOI: 10.1002/ehf2.13760.